Pharma
Pharma
+2
Jul 14, 2026
•
2 min read
Life Biosciences Doses the First Patient as Cellular Rejuvenation Reaches Human Trials
Life Biosciences dosed the first patient in its ER-100 partial epigenetic reprogramming trial and NewLimit raised $435 million for its own first human trial, moving cellular rejuvenation and longevity science from mice into people in 2026.
Pharma
+2
Jul 1, 2026
•
2 min read
The Breakthrough Prize Honors the C9orf72 Discovery Behind ALS and Dementia
The 2026 Breakthrough Prize in Life Sciences recognized Rosa Rademakers and Bryan Traynor, whose 2011 finding named the most common genetic cause of ALS and frontotemporal dementia and opened the door to today's trials.
Pharma
+2
Jul 1, 2026
•
2 min read
Scientists Build SpudCell, the First Synthetic Cell With a Complete Life Cycle
University of Minnesota researchers built SpudCell from non-living chemicals, and it feeds, grows, and divides across five generations, a synthetic biology milestone.
Pharma
+2
Jun 30, 2026
•
2 min read
Edison Taps Its AI Scientist Kosmos to Build New Biotech Companies With PHP
Edison Scientific will deploy its AI scientist Kosmos across the company-creation pipeline of Population Health Partners, the team behind Metsera and The Medicines Company, to build drugmakers for population-scale diseases.
Pharma
+2
Jun 30, 2026
•
1 min read
Conception Says It Has Made the First Human Eggs From Stem Cells
The biotech company led by Matt Krisiloff says it generated early-stage human egg cells from stem cells, an in-vitro gametogenesis milestone with the potential to reshape fertility.
Pharma
+3
Jun 29, 2026
•
2 min read
Tessel Bio Releases Sesame, a Generative Chemistry Model That Fills Any Protein Pocket
Tessel Bio released Sesame, a diffusion-based generative chemistry model that designs drug-like molecules in any protein pocket, de novo or from a chemist's scaffold, with a preprint on arXiv.
Pharma
+2
Apr 12, 2026
•
6 min read
Single Injection Restores Hearing in All Ten Patients in Gene Therapy Trial for Congenital Deafness
A single gene therapy injection restored hearing in all ten patients in a multi-hospital trial published in Nature Medicine, with average hearing thresholds improving from 106 decibels to 52.
Pharma
+3
Apr 12, 2026
•
5 min read
Loyal's LOY-002 Clears Two of Three FDA Gates as the First Longevity Drug Approval in Any Species Nears
Loyal's LOY-002, a daily pill designed to extend healthy lifespan in senior dogs, has cleared two of three FDA technical gates after completing the largest clinical trial in veterinary medicine.
